首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >Genotype-phenotype correlation in hereditary medullary thyroid carcinoma
【24h】

Genotype-phenotype correlation in hereditary medullary thyroid carcinoma

机译:遗传性甲状腺髓样癌的基因型与表型相关性

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: Hereditary medullary thyroid carcinoma (MTC) is caused by germline mutations of the RET proto-oncogene. A genotype - phenotype correlation has been established, showing clustering of mutations in exons 10 and 11 in classical MEN 2 A syndrome, in exon 16 codon 918 in MEN 2 B syndrome and in exons 13-15 in familial MTC. A line of evidence suggested that the development and the aggressiveness of MTC in the different cancer syndromes is variable. Aim of this study was to compare the phenotype of exon 13-15 mutations with that of exon 11 mutation and possibly draw therapeutical consequences. PATIENTS AND METHODS: We compared the phenotype of 47 patients with mutations in exon 13-15 with 66 patients with exon 11, codon 634 mutation, the classical MEN2A. Patients were further subdivided as index and screening patients. RESULTS: Mean age of 19 index patients with codon 790, 791, 804 or 891 mutation was significant higher compared with 18 index patients with codon 634 mutation (mean age at diagnosis 50+/-12 years; range 30-69 y vs mean age 31+/-9 years; range 17-49 y), tumor stage at operation was favourable (C-cell hyperplasia n = 1; stage I n = 8; II n = 3; III n = 2; IV n = 2; no operation n = 1; no information n = 2 vs stage I n = 3; stage II n = 6; stage III n = 4, no information n =5), cure rate was better (56 % vs 38 %) and the death rate was lower (n = 2 vs n = 4). In screening patients no differences concerning the age, tumor stage, cure and death rate between patients with exons 13-15 and codon 634 mutations were seen. CONCLUSIONS: MTC in patients with exon 790, 791, 804, 891 mutations displayed a late onset and an indolent course compared to codon 634 mutation, this has to be taken into account when recomending timing and exent of prophylactic surgery.
机译:背景与目的:遗传性甲状腺髓样癌(MTC)是由RET原癌基因的种系突变引起的。已经建立了基因型与表型的相关性,表明经典MEN 2 A综合征外显子10和11,MEN 2 B综合征外显子16密码子918和家族MTC外显子13-15的突变聚类。一系列证据表明,MTC在不同癌症综合征中的发展和侵略性是可变的。这项研究的目的是比较外显子13-15突变的表型与外显子11突变的表型,并可能得出治疗效果。患者与方法:我们比较了47位外显子13-15突变的患者和66位外显子11,密码子634突变(经典MEN2A)的患者的表型。将患者进一步细分为索引和筛查患者。结果:19位具有790,791,804或891密码子突变的索引患者的平均年龄显着高于18位具有634密码子突变的索引患者(诊断时的平均年龄50 +/- 12岁;范围30-69岁vs平均年龄) 31 +/- 9年;范围17-49岁),手术时肿瘤分期良好(C细胞增生n = 1;分期I n = 8; II n = 3; III n = 2; IV n = 2;无操作n = 1;无信息n = 2与阶段I n = 3;阶段II n = 6;阶段III n = 4,无信息n = 5),治愈率更好(56%比38%),并且死亡率较低(n = 2 vs n = 4)。在筛选患者时,未发现外显子13-15和密码子634突变的患者在年龄,肿瘤分期,治愈率和死亡率方面存在差异。结论:与密码子634突变相比,外显子790、791、804、891突变的MTC表现出较晚的发作和缓慢的病程,在推荐预防性手术的时机和范围时必须考虑这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号